{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T00:56:06Z","timestamp":1719622566475},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1990,1,1]],"date-time":"1990-01-01T00:00:00Z","timestamp":631152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Blut"],"published-print":{"date-parts":[[1990,1]]},"DOI":"10.1007\/bf01720201","type":"journal-article","created":{"date-parts":[[2005,6,12]],"date-time":"2005-06-12T13:24:45Z","timestamp":1118582685000},"page":"37-40","source":"Crossref","is-referenced-by-count":11,"title":["Recombinant interferon-alpha, but not interferon-gamma is effective therapie for essential thrombocythemia"],"prefix":"10.1007","volume":"60","author":[{"given":"M. J. B. P.","family":"Abegg-Werter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M. M.","family":"Raemaekers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. E.","family":"Pauw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Haanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01720201_CR1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0140-6736(88)92625-6","volume":"II","author":"S Bellucci","year":"1988","unstructured":"Bellucci S, Harousseau JL, Brice P, Tobelem G (1988) Treatment of essential thrombocythaemia by alpha 2a interferon. Lancet II: 960\u2013961","journal-title":"Lancet"},{"key":"BF01720201_CR2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood.V63.1.51.51","volume":"63","author":"DC Case Jr","year":"1984","unstructured":"Case DC Jr (1984) Therapy of essential thrombocythemia with thiotepa and chlorambucil. Blood 63: 51\u201354","journal-title":"Blood"},{"key":"BF01720201_CR3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(88)90005-0","volume":"II","author":"FJ Giles","year":"1988","unstructured":"Giles FJ, Gray AG, Brozovic M, Grant IR, Machin SJ, Richards JDM, Venutas S, Singer CRJ, Young KL, Davies SC, Hoffbrand AV, Mehta AB, Thomas MJG, Goldstone AH (1988) Alpha-interferon therapy for essential thrombocythaemia. Lancet II: 70\u201372","journal-title":"Lancet"},{"key":"BF01720201_CR4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0140-6736(89)92142-9","volume":"I","author":"H Gisslinger","year":"1989","unstructured":"Gisslinger H, Linkesch W, Fritz E, Ludwig H, Chott A, Radaszkiewicz Th (1989) Long-term interferon therapy for thrombocytosis in myeloproliferative diseases. Lancet I: 634\u2013637","journal-title":"Lancet"},{"key":"BF01720201_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2141.1989.tb04251.x","volume":"71","author":"L Gugliotta","year":"1989","unstructured":"Gugliotta L, Bagnara GP, Catani L, Gaggioli L, Guarini A, Zauli G, Belmonte MM, Lauria F, Macchi S, Tura S (1989) In vivo and in vitro inhibitory effect of \u03b1-interferon on megakaryocyte colony growth in essential thrombocythaemia. Br J Haematol 71: 177\u2013181","journal-title":"Br J Haematol"},{"key":"BF01720201_CR6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7326\/0003-4819-99-4-513","volume":"99","author":"J Jabaily","year":"1983","unstructured":"Jabaily J, Iland HJ, Laszlo J, Massey EW, Faguet GB, Bri\u00e8re J, Landaw SA, Pisciotta AV (1983) Neurologic manifestations of essential thrombocythemia. Ann Int Med 99: 513\u2013518","journal-title":"Ann Int Med"},{"key":"BF01720201_CR7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1182\/blood.V55.5.711.711","volume":"55","author":"M Krim","year":"1980","unstructured":"Krim M (1980) Towards tumor therapy with interferons, Part I. Interferons: production and properties. Blood 55: 711\u2013721","journal-title":"Blood"},{"key":"BF01720201_CR8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1200\/JCO.1986.4.7.1101","volume":"4","author":"R Kurzrock","year":"1986","unstructured":"Kurzrock R, Quesada JR, Talpaz M, Hersh EM, Reuben JM, Sherwin SA, Gutterman JU (1986) Phase I study of multiple dose intramuscularly administered recombinant gamma interferon. J Clin Oncol 4: 1101\u20131109","journal-title":"J Clin Oncol"},{"key":"BF01720201_CR9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/BF00199157","volume":"25","author":"H Ludwig","year":"1987","unstructured":"Ludwig H, Linkesch W, Gisslinger H, Fritz E, Sinzinger H, Radaszkiewicz T, Chott A, Flener R, Micksche M (1987) Interferon-alpha corrects thrombocytosis in patients with myeloproliferative disorders. Cancer Immunol Immunother 25: 266\u2013273","journal-title":"Cancer Immunol Immunother"},{"key":"BF01720201_CR10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0140-6736(89)91446-3","volume":"I","author":"D May","year":"1989","unstructured":"May D, Wandl UB, Niederle N (1989) Treatment of essential thrombocythaemia with interferon alpha-2b. Lancet I: 96","journal-title":"Lancet"},{"key":"BF01720201_CR11","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2559.1984.tb02379.x","volume":"8","author":"JJ Michiels","year":"1984","unstructured":"Michiels JJ, Kate FWJ ten, Vuzevski VD, Abels J (1984) Histopathology of erythromelalgia in thrombocythaemia. Histopathology 8: 669\u2013678","journal-title":"Histopathology"},{"key":"BF01720201_CR12","first-page":"177","volume":"23","author":"S Murphy","year":"1986","unstructured":"Murphy S, Iland H, Rosenthal D, Laszlo J (1986) Essential thrombocythemia: an interim report from the polycythemia vera study group. Semin Hematol 23: 177\u2013182","journal-title":"Semin Hematol"},{"key":"BF01720201_CR13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1600-0609.1985.tb02270.x","volume":"35","author":"BE Pauw de","year":"1985","unstructured":"Pauw BE de, Bergen ANL van, Haanen C, Steenbergen J (1985) Intermittent melphalan in the treatment of essential thrombocytosis with haemorrhage or thrombosis. Scand J Haematol 35: 448\u2013450","journal-title":"Scand J Haematol"},{"key":"BF01720201_CR14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2141.1986.tb02926.x","volume":"61","author":"JEW Pette van de","year":"1986","unstructured":"Pette JEW van de, Prochazka AV, Pearson TC, Singh AK, Dickson ER, Wetherley-Mein G (1986) Primary thrombocythaemia treated with busulphan. Br J Haematol 61: 229\u2013237","journal-title":"Br J Haematol"},{"key":"BF01720201_CR15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/S0140-6736(82)92021-9","volume":"I","author":"FE Preston","year":"1982","unstructured":"Preston FE (1982) Essential thrombocythaemia. Lancet I: 1021","journal-title":"Lancet"},{"key":"BF01720201_CR16","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1182\/blood.V65.4.858.858","volume":"65","author":"WFC Rigby","year":"1985","unstructured":"Rigby WFC, Ball ED, Guyre PM, Fanger MW (1985) The effects of recombinant-DNA-derived interferons on the growth of myeloid progenitor cells. Blood 65: 858\u2013861","journal-title":"Blood"},{"key":"BF01720201_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V64.1.1.1","volume":"64","author":"AI Schafer","year":"1984","unstructured":"Schafer AI (1984) Bleeding and thrombosis in the myeloproliferative disorders. Blood 64: 1\u201312","journal-title":"Blood"},{"key":"BF01720201_CR18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/0002-9343(77)90424-7","volume":"62","author":"HD Sogtman","year":"1977","unstructured":"Sogtman HD, Matthay RA, Putman CE (1977) Cytotoxic drug induced lung disease. Am J Med 62: 608\u2013615","journal-title":"Am J Med"},{"key":"BF01720201_CR19","doi-asserted-by":"crossref","first-page":"789","DOI":"10.7326\/0003-4819-99-6-789","volume":"99","author":"M Talpaz","year":"1983","unstructured":"Talpaz M, Mavligit G, Keating M, Walters RS, Gutterman JU (1983) Human leukocyte interferon to control thrombocytosis in chronic myelogenous leukemia. Ann Int Med 99: 789\u2013792","journal-title":"Ann Int Med"},{"key":"BF01720201_CR20","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198604243141701","volume":"314","author":"M Talpaz","year":"1986","unstructured":"Talpaz M, Kantarjian HM, McCredie K, Trujillo JM, Keating MJ, Gutterman JU (1986) Hematologic remission and cytogenetic improvement induced by recombinant human interferon alphaA in chronic myelogenous leukemia. N Engl J Med 314: 1065\u20131069","journal-title":"N Engl J Med"},{"key":"BF01720201_CR21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ajh.2830280113","volume":"28","author":"BT Toh","year":"1988","unstructured":"Toh BT, Gregory SA, Knopse WH (1988) Acute leukemia following treatment of polycythemia vera and essential thrombocythemia with uracil mustard. Am J Hematol 28: 58\u201360","journal-title":"Am J Hematol"},{"key":"BF01720201_CR22","first-page":"1","volume":"54","author":"JL Toy","year":"1983","unstructured":"Toy JL (1983) The interferons. Clin Exp Immunol 54: 1\u201313","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 1","key":"BF01720201_CR23","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000226078","volume":"42","author":"T Velu","year":"1985","unstructured":"Velu T, Delwiche F, Gangji D, Monsieur R, Flament J, Stryckmans P, Wybran J, Bellens R (1985) Therapeutic effect of human recombinant interferon-alpha-2 C in essential thrombocythaemia. Oncology 42 [Suppl 1]: 10\u201314","journal-title":"Oncology"}],"container-title":["Blut"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01720201.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01720201\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01720201","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T17:45:31Z","timestamp":1706291131000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01720201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,1]]}},"alternative-id":["BF01720201"],"URL":"https:\/\/doi.org\/10.1007\/bf01720201","relation":{},"ISSN":["0006-5242","1432-0584"],"issn-type":[{"value":"0006-5242","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,1]]}}}